These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15709479)

  • 1. Is the Aluminum Hypothesis dead?
    Lidsky TI
    J Occup Environ Med; 2014 May; 56(5 Suppl):S73-9. PubMed ID: 24806729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
    Vestergaard M; Hamada T; Morita M; Takagi M
    Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol.
    Rudajev V; Novotny J
    Cell Biosci; 2023 Sep; 13(1):171. PubMed ID: 37705117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease.
    Rudajev V; Novotny J
    Front Mol Neurosci; 2022; 15():937056. PubMed ID: 36090253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential associations between apolipoprotein E alleles and cerebral myelin content in normative aging.
    Triebswetter C; Kiely M; Khattar N; Ferrucci L; Resnick SM; Spencer RG; Bouhrara M
    Neuroimage; 2022 May; 251():118988. PubMed ID: 35150834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hidden variables problem in Alzheimer's disease clinical trial design.
    Liyanage SI; Santos C; Weaver DF
    Alzheimers Dement (N Y); 2018; 4():628-635. PubMed ID: 30519628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized cholesterol as the driving force behind the development of Alzheimer's disease.
    Gamba P; Testa G; Gargiulo S; Staurenghi E; Poli G; Leonarduzzi G
    Front Aging Neurosci; 2015; 7():119. PubMed ID: 26150787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism in Alzheimer's disease.
    Liu Q; Zhang J
    Neurosci Bull; 2014 Apr; 30(2):331-45. PubMed ID: 24733655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol as a co-solvent and a ligand for membrane proteins.
    Song Y; Kenworthy AK; Sanders CR
    Protein Sci; 2014 Jan; 23(1):1-22. PubMed ID: 24155031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol.
    Barrett PJ; Song Y; Van Horn WD; Hustedt EJ; Schafer JM; Hadziselimovic A; Beel AJ; Sanders CR
    Science; 2012 Jun; 336(6085):1168-71. PubMed ID: 22654059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases.
    Fantini J; Yahi N
    Expert Rev Mol Med; 2010 Sep; 12():e27. PubMed ID: 20807455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?
    Beel AJ; Sakakura M; Barrett PJ; Sanders CR
    Biochim Biophys Acta; 2010 Aug; 1801(8):975-82. PubMed ID: 20304095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40).
    Yahi N; Aulas A; Fantini J
    PLoS One; 2010 Feb; 5(2):e9079. PubMed ID: 20140095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal death in Alzheimer's disease and therapeutic opportunities.
    Donev R; Kolev M; Millet B; Thome J
    J Cell Mol Med; 2009; 13(11-12):4329-48. PubMed ID: 19725918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol and amyloid beta fibrillogenesis.
    Yanagisawa K
    Subcell Biochem; 2005; 38():179-202. PubMed ID: 15709479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol-dependent aggregation of amyloid beta-protein.
    Yanagisawa K; Matsuzaki K
    Ann N Y Acad Sci; 2002 Nov; 977():384-6. PubMed ID: 12480776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid.
    Kakio A; Nishimoto SI; Yanagisawa K; Kozutsumi Y; Matsuzaki K
    J Biol Chem; 2001 Jul; 276(27):24985-90. PubMed ID: 11342534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.
    Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K
    Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.